Clinical Trial Detail

NCT ID NCT01238237
Title Super-Selective Intraarterial Cerebral Infusion of Cetuximab for the Treatment of Recurrent Glioblastoma Multiforme and Anaplastic Astrocytoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

astrocytoma

glioblastoma multiforme

Therapies

Cetuximab

Age Groups: adult

No variant requirements are available.